This inventor holds 1 USPTO granted patent. Top assignee: Sankyo Company, Limited. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Naoyuki Maeda: Innovator in Pharmaceutical Compositions
Introduction
Naoyuki Maeda is a notable inventor based in Zushi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of arteriosclerosis. His innovative approach combines various active ingredients to enhance therapeutic outcomes.
Latest Patents
Naoyuki Maeda holds 1 patent for his invention titled "Pharmaceutical compositions and methods for the treatment of arteriosclerosis." This patent describes a pharmaceutical composition that includes angiotensin II receptor antagonists and angiotensin converting enzyme inhibitors, along with insulin resistance improving agents. The combination exhibits excellent inhibitory effects on arteriosclerotic progression, making it a valuable drug for prevention and treatment.
Career Highlights
Maeda is associated with Sankyo Company, Limited, where he applies his expertise in pharmaceutical development. His work focuses on creating effective treatments that address critical health issues, such as arteriosclerosis.
Collaborations
Throughout his career, Naoyuki Maeda has collaborated with esteemed colleagues, including Yoshio Tsujita and Toshihiko Fujiwara. These partnerships have contributed to the advancement of his research and the successful development of innovative pharmaceutical solutions.
Conclusion
Naoyuki Maeda's contributions to the field of pharmaceuticals, particularly through his patent for treating arteriosclerosis, highlight his role as an influential inventor. His work continues to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile